Transcription of JCOG0909
1 Japan Clinical Oncology Group 23-A-19 JCOG0909 II/III T4 +/- ver. A non-randomized confirmatory study of definitive chemoradiotherapy including salvage treatment in patients with clinical stage II/III esophageal carcinoma EC-CRT+Salvage- sP3 160-8582 35 142-8666 1-5-8 431-3192 1-20-1 2008 3 1 JCOG PC708 2010 3 10 ver. JCOG 2012 1 26 ver. JCOG 2 7 2013 7 25 ver. JCOG 8 1 2018 8 28 ver. JCOG 2018 10 15 ver.
2 JCOG0909 ver. 2/111 0. 29 16 JCOG II/III T4 +/- +/- II/III T4 Gy 5-FU + CDDP 1000/75 +/- Primary endpoint 3 Secondary endpoints CR 1 JCOG0909 ver. 3/111 2 TNM-UICC 6 2002 3 II T4 III TNM-UICC 6 2002 4 20 75 5 PS ECOG 0 1 6 EMR/ESD pT1a-LPM M2 EMR/ESD pT1a-MM M3 7 5 8 9 10 2 5-FU 1,000 mg/m2/day day 1 4 29 32 CDDP 75 mg/m2 day 1 29 1 Gy 1 1 28 Gy 5-FU 1.
3 000 mg/m2/day day 1 4 CDDP 75 mg/m2 day 1 28 2 Salvage EMR/ESD Salvage surgery 95 3 5 2010 4 26 2020 10 26 CRF JCOG JCOG
